Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Risk of major adverse cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: emulated target trials using routine, de-identified data from South Africa

Dorward J. et al, (2025)

Uptake and 24-month outcomes of dolutegravir- versus lopinavir-based second-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study and emulated target trial

Brown JA. et al, (2025)

Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2023 – cohort description, test volumes, predictors of viraemia and the road ahead

Brown JA. et al, (2025), BMJ Open, 15, e085404 - e085404

Hair salons as a promising space to provide HIV and sexual and reproductive health services for young women in Lesotho: A citizen scientist mixed-methods study

Chiaborelli M. et al, (2024)

Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho

Tschumi N. et al, (2024), Clinical Infectious Diseases, 79, 1208 - 1222

Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial

Brown JA. et al, (2024), The Lancet Global Health, 12, e1312 - e1322

HIV viral suppression in children and adolescents 2 years after transition to dolutegravir: A multicentre cohort study

Devendra A. et al, (2024), AIDS, 38, 1013 - 1023

Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL)

Kohler M. et al, (2024), Open Forum Infectious Diseases, 11

Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 – cohort description, test volumes, predictors of viraemia, and the road ahead

Brown J. et al, (2024)

Emergence of Acquired Dolutegravir Resistance in Treatment-Experienced People with HIV in Lesotho

Tschumi N. et al, (2024)

Two-Year Outcomes of Treatment-Experienced Adults After Programmatic Transitioning to Dolutegravir: Longitudinal Data From the VICONEL Human Immunodeficiency Virus Cohort in Lesotho

Tschumi N. et al, (2023), Clinical Infectious Diseases, 77, 1318 - 1321

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity

Brown JA. et al, (2023), Journal of Infectious Diseases, 228, 1042 - 1054

Treatment Outcomes after Offering Same-Day Initiation of Human Immunodeficiency Virus Treatment-How to Interpret Discrepancies between Different Studies

Labhardt ND. et al, (2023), Clinical Infectious Diseases, 77, 1176 - 1184

Effectiveness of a Peer Educator-Coordinated Preference-Based Differentiated Delivery Model on Viral Suppression Among Young People Living with HIV in Lesotho: The PEBRA Cluster Randomized Trial

Kopo M. et al, (2023)

Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho

Brown JA. et al, (2023), HIV Medicine, 24, 153 - 162

Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial

Kopo M. et al, (2023), PLoS Medicine, 20

HIV Care Preferences among Young People Living with HIV in Lesotho: A Secondary Data Analysis of the PEBRA Cluster Randomized Trial

Seiler O. et al, (2023), AIDS Research and Treatment, 2023

Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trial

Tschumi N. et al, (2022), PLoS ONE, 17

The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa

Muhairwe JA. et al, (2022), Pediatric Infectious Disease Journal, 41, E75 - E80

Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)

Brown JA. et al, (2022), HIV Medicine, 23, 287 - 293

Load More